» Authors » Franz Freudenthal

Franz Freudenthal

Explore the profile of Franz Freudenthal including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 14
Citations 319
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hinkel R, Batkai S, Bahr A, Bozoglu T, Straub S, Borchert T, et al.
J Am Coll Cardiol . 2021 Jun; 77(23):2923-2935. PMID: 34112319
Background: Pathological cardiac hypertrophy is a result of afterload-increasing pathologies including untreated hypertension and aortic stenosis. It features progressive adverse cardiac remodeling, myocardial dysfunction, capillary rarefaction, and interstitial fibrosis often...
2.
Heath A, von Alvensleben I, Navarro J, Echazu G, Kozlik-Feldmann R, Freudenthal F
World J Pediatr Congenit Heart Surg . 2019 Jul; 10(4):433-439. PMID: 31307309
Objective: To assess the efficacy and safety of the Nit-Occlud ASD-R (PFM S.R.L, La Paz, Bolivia) in the percutaneous closure of secundum atrial septal defects (ASD). Patients And Methods: Fifty-three...
3.
Heath A, Javois A, Freudenthal F
JAMA . 2018 Mar; 319(10):966-967. PMID: 29536074
No abstract available.
4.
Lang N, Merkel E, Fuchs F, Schumann D, Klemm D, Kramer F, et al.
Eur J Cardiothorac Surg . 2014 Jul; 47(6):1013-21. PMID: 25064053
Objectives: Current materials for closure of cardiac defects such as ventricular septal defects (VSDs) are associated with compliance mismatch and a chronic inflammatory response. Bacterial nanocellulose (BNC) is a non-degradable...
5.
Lang N, Pereira M, Lee Y, Friehs I, Vasilyev N, Feins E, et al.
Sci Transl Med . 2014 Jan; 6(218):218ra6. PMID: 24401941
Currently, there are no clinically approved surgical glues that are nontoxic, bind strongly to tissue, and work well within wet and highly dynamic environments within the body. This is especially...
6.
Del Cerro M, Abman S, Diaz G, Freudenthal A, Freudenthal F, Harikrishnan S, et al.
Pulm Circ . 2011 Aug; 1(2):286-298. PMID: 21874158
Current classifications of pulmonary hypertension have contributed a great deal to our understanding of pulmonary vascular disease, facilitated drug trials, and improved our understanding of congenital heart disease in adult...
7.
Lammers A, Adatia I, Del Cerro M, Diaz G, Freudenthal A, Freudenthal F, et al.
Pulm Circ . 2011 Aug; 1(2):280-285. PMID: 21874157
The members of the Pediatric Task Force of the Pulmonary Vascular Research Institute (PVRI) were aware of the need to develop a functional classification of pulmonary hypertension in children. The...
8.
Heath A, Lang N, Levi D, Granja M, Villanueva J, Navarro J, et al.
Catheter Cardiovasc Interv . 2011 Aug; 79(3):399-407. PMID: 21805617
Background: Patent ducti arteriosi (PDAs) are more frequent and larger at high altitude than at sea level. A novel PDA closure device, the Nitocclud PDA-R, is designed specifically for both...
9.
Lang N, Schmitz C, Lehner A, Fuchs F, Heath A, Freudenthal F, et al.
Catheter Cardiovasc Interv . 2009 Nov; 75(3):408-15. PMID: 19882712
Objectives: Aim of our study was the preclinical evaluation of a new self expanding device for interventional closure of muscular ventricular septal defects (mVSDs) in an acute pig model. Background:...
10.
Sodian R, Schmauss D, Schmitz C, Bigdeli A, Haeberle S, Schmoeckel M, et al.
Ann Thorac Surg . 2009 Aug; 88(3):974-8. PMID: 19699931
Purpose: The objective of this study was to show the use of 3-dimensional printing models to fabricate a custom-made occluder for device embolization of an anastomotic leak after replacement of...